1. Home
  2. INN
  3. INN News

Latest Summit Hotel Properties Inc. (INN) News on October 24, 2025

How Recent Analyst Shifts Are Changing the Story for Summit Hotel Properties
INN

Simply Wall St.

18 days ago

How Recent Analyst Shifts Are Changing the Story for Summit Hotel Properties

SUMMIT HOTEL PROPERTIES ANNOUNCES SECOND QUARTER 2025 EARNINGS RELEASE DATE
INN

PR Newswire

4 months ago

SUMMIT HOTEL PROPERTIES ANNOUNCES SECOND QUARTER 2025 EARNINGS RELEASE DATE

INN

Argus Research

4 months ago

INN: Rating increased to a HOLD

Innocan Pharma Announces Presentation of Narrative Review on Long-Acting Synthetic Cannabidiol for Chronic Pain at PAINWEEK Conference
INN

CNW Group

4 months ago

Innocan Pharma Announces Presentation of Narrative Review on Long-Acting Synthetic Cannabidiol for Chronic Pain at PAINWEEK Conference

Innocan Pharma Highlights Breakthrough Narrative Review on Liposomal Synthetic CBD for Chronic Pain: A Novel Non-Opioid Analgesic Approach
INN

CNW Group

4 months ago

Innocan Pharma Highlights Breakthrough Narrative Review on Liposomal Synthetic CBD for Chronic Pain: A Novel Non-Opioid Analgesic Approach

INN

Argus Research

4 months ago

INN: Raising target price to $4.00

Innocan Pharma Announces First Quarter 2025 Financial Results with Continued Strong Revenue Growth and Provides Corporate Update
INN

CNW Group

5 months ago

Innocan Pharma Announces First Quarter 2025 Financial Results with Continued Strong Revenue Growth and Provides Corporate Update

INN

Argus Research

5 months ago

INN: Rating decreased to a SELL

INN

Argus Research

5 months ago

INN: Raising target price to $5.00

INN

Argus Research

6 months ago

INN: What does Argus have to say about INN?

Innocan Pharma First Granted Patent in Mexico for its Topical Pain Relief
INN

CNW Group

6 months ago

Innocan Pharma First Granted Patent in Mexico for its Topical Pain Relief

Summit Hotel Properties Inc (INN) Q1 2025 Earnings Call Highlights: Navigating Growth and Challenges
INN

GuruFocus.com

6 months ago

Summit Hotel Properties Inc (INN) Q1 2025 Earnings Call Highlights: Navigating Growth and Challenges

INN

Thomson Reuters StreetEvents

6 months ago

Q1 2025 Summit Hotel Properties Inc Earnings Call

Summit Hotel Properties (INN) Beats Q1 FFO Estimates
INN

Zacks

6 months ago

Summit Hotel Properties (INN) Beats Q1 FFO Estimates

INN

Associated Press Finance

6 months ago

Summit Hotel Properties: Q1 Earnings Snapshot

SUMMIT HOTEL PROPERTIES REPORTS FIRST QUARTER 2025 RESULTS
INN

PR Newswire

6 months ago

SUMMIT HOTEL PROPERTIES REPORTS FIRST QUARTER 2025 RESULTS

INN

MT Newswires

6 months ago

BofA Upgrades Summit Hotel Properties to Neutral

INN or OHI: Which Is the Better Value Stock Right Now?
INN

Zacks

6 months ago

INN or OHI: Which Is the Better Value Stock Right Now?

SUMMIT HOTEL PROPERTIES DECLARES FIRST QUARTER 2025 DIVIDENDS
INN

PR Newswire

6 months ago

SUMMIT HOTEL PROPERTIES DECLARES FIRST QUARTER 2025 DIVIDENDS

Is the Options Market Predicting a Spike in Summit Hotel Properties Stock?
INN

Zacks

6 months ago

Is the Options Market Predicting a Spike in Summit Hotel Properties Stock?

INN

Argus Research

6 months ago

INN: What does Argus have to say about INN?

INN

MT Newswires

6 months ago

BofA Securities Adjusts Summit Hotel Properties Price Target to $5 From $7

INN

Argus Research

6 months ago

INN: What does Argus have to say about INN?

Innocan Pharma Announces Closing of Private Placement
INN

CNW Group

6 months ago

Innocan Pharma Announces Closing of Private Placement

INN

Argus Research

7 months ago

INN: Rating decreased to a HOLD

Innocan Pharma Broadens Intellectual Property Coverage for its Liposomal CBD Injection Across Asia and Announces Private Placement of Units
INN

CNW Group

7 months ago

Innocan Pharma Broadens Intellectual Property Coverage for its Liposomal CBD Injection Across Asia and Announces Private Placement of Units

How Much Would It Take To Earn $100 A Month From Summit Hotel Properties Stock
INN

Benzinga

7 months ago

How Much Would It Take To Earn $100 A Month From Summit Hotel Properties Stock

INN

Argus Research

7 months ago

INN: Lowering target price to $6.00

SUMMIT HOTEL PROPERTIES COMPLETES $275 MILLION DELAYED DRAW TERM LOAN FINANCING
INN

PR Newswire

7 months ago

SUMMIT HOTEL PROPERTIES COMPLETES $275 MILLION DELAYED DRAW TERM LOAN FINANCING

Innocan Pharma Reports Full Year 2024 Results with Revenues more than Doubling to US $29.4 million
INN

CNW Group

7 months ago

Innocan Pharma Reports Full Year 2024 Results with Revenues more than Doubling to US $29.4 million

SUMMIT HOTEL PROPERTIES ANNOUNCES FIRST QUARTER 2025 EARNINGS RELEASE DATE
INN

PR Newswire

7 months ago

SUMMIT HOTEL PROPERTIES ANNOUNCES FIRST QUARTER 2025 EARNINGS RELEASE DATE

INN

Argus Research

7 months ago

INN: What does Argus have to say about INN?

INN or NHI: Which Is the Better Value Stock Right Now?
INN

Zacks

7 months ago

INN or NHI: Which Is the Better Value Stock Right Now?

Are Investors Undervaluing Summit Hotel Properties (INN) Right Now?
INN

Zacks

7 months ago

Are Investors Undervaluing Summit Hotel Properties (INN) Right Now?

Innocan Pharma Announces Closing of Debenture Unit Offering to its Largest Shareholder, Tamar Innovest Limited
INN

CNW Group

8 months ago

Innocan Pharma Announces Closing of Debenture Unit Offering to its Largest Shareholder, Tamar Innovest Limited

INN

Argus Research

8 months ago

INN: Lowering target price to $7.00

Innocan Pharma Announces Private Placement Offering of a Debenture Unit to its Largest Shareholder, Tamar Innovest
INN

CNW Group

8 months ago

Innocan Pharma Announces Private Placement Offering of a Debenture Unit to its Largest Shareholder, Tamar Innovest

INN vs. GLPI: Which Stock Is the Better Value Option?
INN

Zacks

8 months ago

INN vs. GLPI: Which Stock Is the Better Value Option?

Should Value Investors Buy Summit Hotel Properties (INN) Stock?
INN

Zacks

8 months ago

Should Value Investors Buy Summit Hotel Properties (INN) Stock?

Summit Hotel Properties Inc (INN) Q4 2024 Earnings Call Highlights: Strong AFFO Growth and ...
INN

GuruFocus.com

8 months ago

Summit Hotel Properties Inc (INN) Q4 2024 Earnings Call Highlights: Strong AFFO Growth and ...

INN

Thomson Reuters StreetEvents

8 months ago

Q4 2024 Summit Hotel Properties Inc Earnings Call

INN

Argus Research

8 months ago

INN: Raising target price to $8.00

Earnings To Watch: Summit Hotel Properties Inc (INN) Reports Q4 2024 Result
INN

GuruFocus.com

8 months ago

Earnings To Watch: Summit Hotel Properties Inc (INN) Reports Q4 2024 Result

Summit Hotel Properties (INN) Q4 FFO and Revenues Beat Estimates
INN

Zacks

8 months ago

Summit Hotel Properties (INN) Q4 FFO and Revenues Beat Estimates

INN

Associated Press Finance

8 months ago

Summit Hotel Properties: Q4 Earnings Snapshot

SUMMIT HOTEL PROPERTIES REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS
INN

PR Newswire

8 months ago

SUMMIT HOTEL PROPERTIES REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS

Earnings To Watch: Summit Hotel Properties Inc (INN) Reports Q4 2024 Result
INN

GuruFocus.com

8 months ago

Earnings To Watch: Summit Hotel Properties Inc (INN) Reports Q4 2024 Result

Summit Hotel Properties Announces 2025 Annual Meeting of Stockholders
INN

PR Newswire

8 months ago

Summit Hotel Properties Announces 2025 Annual Meeting of Stockholders

Park Hotels & Resorts (PK) Q4 FFO Miss Estimates
INN

Zacks

8 months ago

Park Hotels & Resorts (PK) Q4 FFO Miss Estimates

INN

Argus Research

8 months ago

INN: What does Argus have to say about INN?

Summit Hotel Properties (INN): Among the Best Hotel Stocks to Buy According to Analysts
INN

Insider Monkey

8 months ago

Summit Hotel Properties (INN): Among the Best Hotel Stocks to Buy According to Analysts

Innocan Pharma's Liposomal CBD Injection Shows Breakthrough Pain Relief in Elderly Donkey with Osteoarthritis
INN

CNW Group

8 months ago

Innocan Pharma's Liposomal CBD Injection Shows Breakthrough Pain Relief in Elderly Donkey with Osteoarthritis

INN

Argus Research

9 months ago

INN: Lowering target price to $7.00

Innocan Pharma's Subsidiary BI Sky Global Completes HRIPT Testing and Surpasses Important Sales Milestone
INN

CNW Group

9 months ago

Innocan Pharma's Subsidiary BI Sky Global Completes HRIPT Testing and Surpasses Important Sales Milestone

INN

Argus Research

9 months ago

INN: What does Argus have to say about INN?

INN

MT Newswires

9 months ago

BofA Securities Adjusts Summit Hotel Properties Price Target to $7 From $6.50

SUMMIT HOTEL PROPERTIES DECLARES FOURTH QUARTER 2024 DIVIDENDS
INN

PR Newswire

9 months ago

SUMMIT HOTEL PROPERTIES DECLARES FOURTH QUARTER 2024 DIVIDENDS

INN

Argus Research

9 months ago

INN: Raising target price to $8.00

INN

Argus Research

9 months ago

INN: What does Argus have to say about INN?

SUMMIT HOTEL PROPERTIES ANNOUNCES FOURTH QUARTER AND FULL YEAR 2024 EARNINGS RELEASE DATE
INN

PR Newswire

9 months ago

SUMMIT HOTEL PROPERTIES ANNOUNCES FOURTH QUARTER AND FULL YEAR 2024 EARNINGS RELEASE DATE

FDA's Center for Veterinary Medicine Grants Innocan Pharma a Fee Waiver for 2025
INN

CNW Group

9 months ago

FDA's Center for Veterinary Medicine Grants Innocan Pharma a Fee Waiver for 2025

Innocan Pharma Announces Closing of Private Placement for Gross Proceeds of C$635,444.60
INN

CNW Group

10 months ago

Innocan Pharma Announces Closing of Private Placement for Gross Proceeds of C$635,444.60

INN

Argus Research

10 months ago

INN: Rating increased to a BUY

Innocan Pharma Announces Private Placement of Units
INN

CNW Group

10 months ago

Innocan Pharma Announces Private Placement of Units

INN

Argus Research

10 months ago

INN: What does Argus have to say about INN?

Innocan Pharma Provides its Annual "State of Research and Development" Update for 2024
INN

CNW Group

10 months ago

Innocan Pharma Provides its Annual "State of Research and Development" Update for 2024

INN

Argus Research

10 months ago

INN: What does Argus have to say about INN?

Summit Hotel Properties Announces Pending Acquisition of Two-Hotel Portfolio for $96 Million Through GIC Joint Venture
INN

PR Newswire

10 months ago

Summit Hotel Properties Announces Pending Acquisition of Two-Hotel Portfolio for $96 Million Through GIC Joint Venture

INN

Argus Research

a year ago

INN: What does Argus have to say about INN?

Innocan Pharma Announces Encouraging Results from a Safety Assessment Study of LPT-CBD on Minipigs
INN

CNW Group

a year ago

Innocan Pharma Announces Encouraging Results from a Safety Assessment Study of LPT-CBD on Minipigs

Innocan Pharma Reports Third Quarter 2024 Financial Results
INN

CNW Group

a year ago

Innocan Pharma Reports Third Quarter 2024 Financial Results

How To Put $100 In Your Retirement Fund Each Month With Summit Hotel Properties Stock
INN

Benzinga

a year ago

How To Put $100 In Your Retirement Fund Each Month With Summit Hotel Properties Stock

INN

Argus Research

a year ago

INN: Rating increased to a BUY

Innocan to Direct Full Focus on Following Positive FDA Engagement and Significant Potential Market Demand
INN

CNW Group

a year ago

Innocan to Direct Full Focus on Following Positive FDA Engagement and Significant Potential Market Demand

Summit Hotel Properties Inc (INN) Q3 2024 Earnings Call Highlights: Navigating Challenges and ...
INN

GuruFocus.com

a year ago

Summit Hotel Properties Inc (INN) Q3 2024 Earnings Call Highlights: Navigating Challenges and ...

INN

Thomson Reuters StreetEvents

a year ago

Q3 2024 Summit Hotel Properties Inc Earnings Call

INN

Argus Research

a year ago

INN: Lowering target price to $6.00

Summit Hotel Properties (INN) Q3 FFO and Revenues Beat Estimates
INN

Zacks

a year ago

Summit Hotel Properties (INN) Q3 FFO and Revenues Beat Estimates

INN

Associated Press Finance

a year ago

Summit Hotel Properties: Q3 Earnings Snapshot

SUMMIT HOTEL PROPERTIES REPORTS THIRD QUARTER 2024 RESULTS
INN

PR Newswire

a year ago

SUMMIT HOTEL PROPERTIES REPORTS THIRD QUARTER 2024 RESULTS

Summit Hotel Properties Inc (INN) Q3 2024 Earnings Report Preview: What To Expect
INN

GuruFocus.com

a year ago

Summit Hotel Properties Inc (INN) Q3 2024 Earnings Report Preview: What To Expect

Earnings To Watch: Summit Hotel Properties Inc (INN) Reports Q3 2024 Result
INN

GuruFocus.com

a year ago

Earnings To Watch: Summit Hotel Properties Inc (INN) Reports Q3 2024 Result

SUMMIT HOTEL PROPERTIES DECLARES THIRD QUARTER 2024 DIVIDENDS
INN

PR Newswire

a year ago

SUMMIT HOTEL PROPERTIES DECLARES THIRD QUARTER 2024 DIVIDENDS

Innocan Pharma to Present at the 2024 ThinkEquity Conference
INN

GlobeNewswire

a year ago

Innocan Pharma to Present at the 2024 ThinkEquity Conference

Innocan Pharma to Participate at the ThinkEquity 2024 Investor Conference in New York Also Announces Relaunch of Updated Website for Enhanced Investor Experience
INN

CNW Group

a year ago

Innocan Pharma to Participate at the ThinkEquity 2024 Investor Conference in New York Also Announces Relaunch of Updated Website for Enhanced Investor Experience

Innocan Pharma's LPT-CBD Shows Long-Term Success in Relieving Osteoarthritis Pain in Dogs
INN

CNW Group

a year ago

Innocan Pharma's LPT-CBD Shows Long-Term Success in Relieving Osteoarthritis Pain in Dogs

Summit Hotel Properties (INN) Shows Fast-paced Momentum But Is Still a Bargain Stock
INN

Zacks

a year ago

Summit Hotel Properties (INN) Shows Fast-paced Momentum But Is Still a Bargain Stock

Innocan Pharma Celebrates Dr. Joseph Pergolizzi's Recognition Among Stanford University's List of the Top 2% Most-Cited Scientists Worldwide
INN

CNW Group

a year ago

Innocan Pharma Celebrates Dr. Joseph Pergolizzi's Recognition Among Stanford University's List of the Top 2% Most-Cited Scientists Worldwide

INN

Argus Research

a year ago

INN: Rating decreased to a HOLD

Summit Hotel Properties, Inc. (INN) Hit a 52 Week High, Can the Run Continue?
INN

Zacks

a year ago

Summit Hotel Properties, Inc. (INN) Hit a 52 Week High, Can the Run Continue?

Are Investors Undervaluing Summit Hotel Properties (INN) Right Now?
INN

Zacks

a year ago

Are Investors Undervaluing Summit Hotel Properties (INN) Right Now?

SUMMIT HOTEL PROPERTIES ANNOUNCES THIRD QUARTER 2024 EARNINGS RELEASE DATE
INN

PR Newswire

a year ago

SUMMIT HOTEL PROPERTIES ANNOUNCES THIRD QUARTER 2024 EARNINGS RELEASE DATE

SUMMIT HOTEL PROPERTIES PUBLISHES 2024 CORPORATE RESPONSIBILITY REPORT
INN

PR Newswire

a year ago

SUMMIT HOTEL PROPERTIES PUBLISHES 2024 CORPORATE RESPONSIBILITY REPORT

Innocan Pharma Advances Liposomal CBD with Positive Response from FDA Following Successful Pre-IND Meeting
INN

CNW Group

a year ago

Innocan Pharma Advances Liposomal CBD with Positive Response from FDA Following Successful Pre-IND Meeting

Innocan Pharma Announces Closing of Private Placement and Grant of Stock Options
INN

CNW Group

a year ago

Innocan Pharma Announces Closing of Private Placement and Grant of Stock Options

INN

Argus Research

a year ago

INN: What does Argus have to say about INN?

Innocan Pharma's Subsidiary BI Sky Global Successfully Completes FDA MoCRA Registration
INN

CNW Group

a year ago

Innocan Pharma's Subsidiary BI Sky Global Successfully Completes FDA MoCRA Registration

INN

Argus Research

a year ago

INN: What does Argus have to say about INN?

Innocan Pharma Reports Second Quarter 2024 Results with Revenue Growth of over 2.8X to $8.6 Million
INN

CNW Group

a year ago

Innocan Pharma Reports Second Quarter 2024 Results with Revenue Growth of over 2.8X to $8.6 Million

Here Is Why Bargain Hunters Would Love Fast-paced Mover Summit Hotel Properties (INN)
INN

Zacks

a year ago

Here Is Why Bargain Hunters Would Love Fast-paced Mover Summit Hotel Properties (INN)

Share on Social Networks: